| Typicality: | 0.550 |
| Saliency: | 0.456 |
| in canada | 12 | location |
| from the year | 10 | temporal |
| by the fda | 5 | other |
| drug → be approved for → marketing | 76 |
| drug → be approved for → the market | 8 |
| drug → be approved for → market | 8 |
| negative | neutral | positive |
| 0.120 | 0.674 | 0.206 |
| Raw frequency | 92 |
| Normalized frequency | 0.456 |
| Modifier score | 0.825 |
| Perplexity | 146.318 |